Department of Pain Medicine, St James's Hospital, Dublin 8, Ireland.
Department of Pain Medicine, St James's Hospital, Dublin 8, Ireland.
J Neuroimmunol. 2020 Jun 15;343:577219. doi: 10.1016/j.jneuroim.2020.577219. Epub 2020 Mar 19.
Chronic radicular neuropathic pain is a major clinical problem with a life time prevalence of more than 50%. Pulsed radiofrequency (PRF) treatment is a recognised therapy. However, the pathophysiology of chronic neuropathic pain (CNP) and the mechanism of action of PRF remains ill-defined. Improving our knowledge of the mechanisms of CNP and PRF action will enhance our ability to treat patients with this common debilitating problem more effectively. This study aims to characterise the CSF cellular and peptide constituents in patients with CNP and the effect of pulsed radiofrequency (PRF) on these constituents and reported pain.
Prospective randomised tripled-blinded control trial of patients receiving PRF treatment versus sham for radicular pain. All patients received local anaesthetic to the appropriate dermatome to confirm diagnosis. Clinical assessment using standard clinical assessment tools and examination of CSF using flow cytometry and ELISA for cellular and peptide constituents was carried out before and 3 months after treatment.
Ten patients were randomised to PRF (n = 5) or Sham (n = 5) treatment. PRF resulted in a significant reduction in pain score (NRS) at 3 months (6.8 to 2.6, p < .05). PRF reduced the TNF-α concentration and CD3+ count in CSF. CD4/CD8 ratio of patients with CNP was lower than historical controls (1.4 versus 3.0-4.2). The majority of CD3+ cells in the CNP patients were activated effector memory cells (80%) versus the surveillance central memory cells (85%) seen in healthy controls.
PRF is superior to local anaesthetic administration for the management of radicular pain and is associated with CSF constituent modulation in vivo. Patients with CNP have lymphocyte characteristics which suggest immune activation.
慢性根性神经病理性疼痛是一个主要的临床问题,终生患病率超过 50%。脉冲射频(PRF)治疗是一种公认的治疗方法。然而,慢性神经病理性疼痛(CNP)的病理生理学和 PRF 的作用机制仍未明确。提高我们对 CNP 机制和 PRF 作用的认识,将增强我们有效治疗这种常见致残性问题的能力。本研究旨在描述 CNP 患者 CSF 的细胞和肽成分,以及脉冲射频(PRF)对这些成分和报告疼痛的影响。
对接受 PRF 治疗和假治疗的根性疼痛患者进行前瞻性随机三盲对照试验。所有患者均接受局部麻醉至相应的皮节以确认诊断。在治疗前和治疗后 3 个月,使用标准临床评估工具进行临床评估,并使用流式细胞术和 ELISA 检查 CSF 的细胞和肽成分。
10 名患者被随机分为 PRF(n=5)或假治疗(n=5)组。PRF 治疗 3 个月后疼痛评分(NRS)显著降低(6.8 至 2.6,p<0.05)。PRF 降低了 CSF 中的 TNF-α浓度和 CD3+计数。CNP 患者的 CD4/CD8 比值低于历史对照(1.4 对 3.0-4.2)。CNP 患者的大多数 CD3+细胞为活化效应记忆细胞(80%),而健康对照中为监视中央记忆细胞(85%)。
PRF 治疗根性疼痛优于局部麻醉,并且与 CSF 成分的体内调节有关。CNP 患者具有淋巴细胞特征,提示免疫激活。